462 WHOLE BODY KNOCKOUT AND LIVER-SPECIFIC KNOCKDOWN OF S100A11 ATTENUATES MURINE METABOLIC DYSFUNCTIONASSOCIATED STEATOHEPATITIS (MASH)
2024 · Gastroenterology · 0 citations
https://doi.org/10.1016/s0016-5085(24)04008-3
N
Naresh Golla
Mayo Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
9
Citations
1
h-index
0
i10-index
Naresh Golla is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Advanced Glycation End Products research & Liver Disease Diagnosis and Treatment & S100 Proteins and Annexins. The author has an h-index of 1, co-authored 5 publications.
Papers by this author
worksSilencing of S100A11 attenuates murine metabolic dysfunction-associated steatohepatitis
2025 · npj gut and liver. · 0 citations
https://doi.org/10.1038/s44355-025-00044-w
Publisher Correction: Silencing of S100A11 attenuates murine metabolic dysfunction-associated steatohepatitis
2026 · npj gut and liver. · 0 citations
https://doi.org/10.1038/s44355-025-00051-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat